3-38894609-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2
The NM_001349253.2(SCN11A):c.2759C>T(p.Ala920Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000781 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A920G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001349253.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant hereditary sensory and autonomic neuropathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial episodic pain syndrome with predominantly lower limb involvementInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary sensory and autonomic neuropathy type 7Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001349253.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN11A | NM_001349253.2 | MANE Select | c.2759C>T | p.Ala920Val | missense | Exon 19 of 30 | NP_001336182.1 | ||
| SCN11A | NM_014139.3 | c.2759C>T | p.Ala920Val | missense | Exon 15 of 26 | NP_054858.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN11A | ENST00000302328.9 | TSL:5 MANE Select | c.2759C>T | p.Ala920Val | missense | Exon 19 of 30 | ENSP00000307599.3 | ||
| SCN11A | ENST00000668754.1 | c.2759C>T | p.Ala920Val | missense | Exon 22 of 33 | ENSP00000499569.1 | |||
| SCN11A | ENST00000456224.7 | TSL:5 | c.2759C>T | p.Ala920Val | missense | Exon 15 of 25 | ENSP00000416757.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152104Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000677 AC: 17AN: 251274 AF XY: 0.0000884 show subpopulations
GnomAD4 exome AF: 0.0000835 AC: 122AN: 1461800Hom.: 0 Cov.: 31 AF XY: 0.000100 AC XY: 73AN XY: 727200 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74294 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Hereditary sensory and autonomic neuropathy type 7;C3809899:Familial episodic pain syndrome with predominantly lower limb involvement Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 920 of the SCN11A protein (p.Ala920Val). This variant is present in population databases (rs759694252, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of SCN11A-related conditions (PMID: 34169998). ClinVar contains an entry for this variant (Variation ID: 474711). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN11A protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at